JT

Jonathan Alexander Terrett

CA Crispr Therapeutics Ag: 8 patents #2 of 16Top 15%
CT Cytomx Therapeutics: 2 patents #9 of 28Top 35%
OB Oxford Biotherapeutics: 1 patents #1 of 2Top 50%
📍 Cambridge, MA: #20 of 1,823 inventorsTop 2%
🗺 Massachusetts: #109 of 14,123 inventorsTop 1%
Overall (2021): #6,709 of 548,734Top 2%
11
Patents 2021

Issued Patents 2021

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11207351 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-12-28
11202802 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-12-21
11191783 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-12-07
11174316 Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof James William West, Li Mei, Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter +2 more 2021-11-16
11166985 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-11-09
11135247 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-10-05
11071755 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-07-27
11046759 Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof Stephen Moore, Margaret Thy Luu Nguyen, Daniel Robert Hostetter, Olga Vasiljeva, Jason Gary Sagert +1 more 2021-06-29
11013767 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-05-25
10982005 Antibodies to bone marrow stromal antigen 1 Christian Rohlff 2021-04-20
10881689 Materials and methods for engineering cells and uses thereof in immuno-oncology Demetrios Kalaitzidis, Lawrence Klein 2021-01-05